%PDF-1.4
%
1 0 obj
<>
endobj
2 0 obj
<>stream
2014-03-06T17:14:40Z
Pages
2014-03-06T11:15:44-06:00
2014-03-06T11:15:44-06:00
Adobe Mac PDF Plug-in
application/pdf
imac5
Ghiselli-MesoblastAnnouncementFeb2014[1].pages
uuid:986aa9b7-f2a6-d34b-85cd-8ab05cff1a99
uuid:2f246bc7-e2e2-4643-b1db-97f37e1be5ac
endstream
endobj
3 0 obj
<>
endobj
5 0 obj
<>/ExtGState<>/Font<>/ProcSet[/PDF/Text]>>/Type/Page>>
endobj
6 0 obj
<>/ExtGState<>/Font<>/ProcSet[/PDF/Text]>>/Type/Page>>
endobj
7 0 obj
<>/ExtGState<>/Font<>/ProcSet[/PDF/Text]>>/Type/Page>>
endobj
8 0 obj
<>/ExtGState<>/Font<>/ProcSet[/PDF/Text]>>/Type/Page>>
endobj
25 0 obj
<>stream
/CS0 cs 1 scn
/GS0 gs
0 0 612 792 re
f
0 0 612 792 re
f
BT
0 scn
/TT0 1 Tf
9 0 0 9 36 747 Tm
[(Abo)1(ut Meso)1(blast)]TJ
/CS1 cs 0 0 0 scn
/TT1 1 Tf
0 -1.222 TD
[(Mesoblast Limited \(A)5(SX:MSB)1(; USO)24(T)19(C:MB)1(L)83(TY\) is a world leader in the dev)9(elopment of biologic products for the broad )]TJ
T*
[(field of regener)18(ativ)9(e medicine. The Compan)10(y\222)35(s proprietary )1(technologies include its highly )1(purified, )]TJ
0 -1.222 TD
[(immunoselected Stro-1/Stro-3 positiv)9(e Mesench)10(ymal Precursor Cells \(MPCs\), culture-expanded Mesench)10(ym)1(al Stem )]TJ
0 -1.222 TD
[(Cells \(MSCs\), D)1(ental Pulp Stem Cells \(D)1(PSCs\), and expanded H)-1(ematopoietic Stem Cells \(HSCs\). Mesoblast)-10(\222)35(s protein )]TJ
T*
[(technologies are based on factors )1(deriv)9(ed from its proprietary )1(cellular platforms, including Stromal D)1(eriv)9(ed )1(F)49(actor)10(-1 )]TJ
T*
[(\(SD)1(F-1\). Mesoblast)-10(\222)35(s allogeneic )1(or \221off)25(-the-shelf)-24(\222 regener)18(ativ)9(e medicine products are being dev)9(eloped )1(for the )]TJ
0 -1.222 TD
[(treatment of conditions with significant unmet medica)1(l needs. Product dev)9(elopment focus is in four major and distinct )]TJ
0 -1.222 TD
[(areas - systemic diseases with )1(an underlying infla)1(mma)1(tory and immunologic )1(etiology; cardiac and v)20(ascular diseases; )]TJ
T*
[(orthopedic diseases of the spine; and impro)7(ving outcomes of bone marrow tr)18(ansplantation associated with oncology )1(or)-25( )]TJ
T*
(genetic conditions. )Tj
0 0 1 scn
[(www)34(.mesoblast.com)]TJ
ET
/CS1 CS 0 0 1 SCN
0.527 w
q 1 0 0 1 124.1191 636.5276 cm
0 0 m
93.226 0 l
S
Q
BT
/CS0 cs 0 scn
/TT0 1 Tf
9 0 0 9 36 615 Tm
[(Abo)1(ut Dr. Gary Ghiselli)]TJ
/TT1 1 Tf
T*
[(D)1(r)142(. Gary Ghiselli is a fellowship-tr)18(ained spine surgeon pr)18(a)1(cticing in Green)5(wood Village, CO)15(. D)1(r)142(. Ghiselli w)9(as educated at)-14( )]TJ
T*
[(UCLA \(B)1(achelor of Science, B)1(iochemistry\), Univ)9(ersit)5(y of )1(T)107(exas South)5(western Medical School \(Summa Cum Laude\), )]TJ
0 -1.222 TD
[(UCLA D)1(epartment of Gener)18(al Surgery \(intern and resident\), Case W)49(estern R)24(eserv)9(e Univ)9(ersit)5(y )1(Hospitals, Clev)9(eland, OH)-189( )]TJ
0 -1.222 TD
[(\(spine fellow\). D)1(r)142(. Ghiselli has receiv)9(ed man)10(y honors and a)5(w)9(ards and is widely )1(published in his field. He participates )]TJ
T*
[(regularly in FD)1(A and other clinical trials - he w)9(as a clinical in)10(v)9(estigator in this Mesoblast Spinal D)1(isc )1(R)24(epair )1(trial.)]TJ
/TT2 1 Tf
0 -2.667 TD
(For further information, please contact:)Tj
/TT1 1 Tf
0 -2.444 TD
(Julie Meldrum)Tj
0 -1.222 TD
[(Corpor)18(ate Communications)]TJ
0 -1.222 TD
(Mesoblast Limited)Tj
0 -1.222 TD
[(T)97(:)-1( +)-1(61 \()-1(0\))-1( 3 9639 6036)]TJ
T*
(E: julie.meldrum@mesoblast.com)Tj
/CS1 cs 0.122 0.286 0.49 scn
( )Tj
/CS0 cs 0 scn
0 -2.778 TD
(Heidi Ghiselli)Tj
0 -1.222 TD
[(P)24(atient & Pro)7(vider Liaison)]TJ
T*
[(D)1(en)10(v)9(er Spine Surgeons)]TJ
0 -1.222 TD
[(T)97(:)-1( 303-)-1(667-)-1(3137)]TJ
0 -1.222 TD
(E: )Tj
/CS1 cs 0 0 1 scn
1.438 0 Td
[(hghiselli@den)10(v)9(erspinesurgeons.com)]TJ
ET
q 1 0 0 1 48.9419 400.5277 cm
0 0 m
163.995 0 l
S
Q
endstream
endobj
14 0 obj
<>
endobj
17 0 obj
<>
endobj
26 0 obj
<>
endobj
29 0 obj
<>
endobj
30 0 obj
<>stream
H
l}wg;Iq87
`E؉!J`ZKBV'PX`Hںq`Dmu(&TUb1iZxNJ}|}04xؽcOΛ6hz
Y YDc&NX^d[/#(ܙo#hۼ;ZW Q+;nB?I#lL?Gl鞙I-;?yd~!ۀi|%UyPd@գوs` #pY'a}g>Nǒwލ}ƽ2P\AmLRvɆ>
*.' N)7$
߃7B84a_
0a^Pk1J0{^W۰[19ψ I3OH^?o'gu@N):ha}:NIT<waSc]v.tTJK"_XokMFױZFVJ"Bcy&B*MϛKKt AE{gˆ xSDȻSZ)<_,A
Rδ+1'ztU0#G" T04F6R2:$$ >;AD%''F`F$Ob}7*?V9+Ȉ70sQq@oǀ<#B
!qQNG7P}f}aa&i1X
ne2CwK\t8 b(ΪTL"}}Q@Q|U|Pz0ѯ[bb $o!%@L?fDH"Jҕ!ReDdf4 ݼ+C".mAOĻھҒ%D"b\N4єpw@Fb0E>ģɡ.ҥ@wmx
K\4aCxl![
KY!D
mw zʍۀ5NMQOlz|iTBP{(Ee{N#"K&f$9dЌdV=".gS1GҖ9)$C=)dhNa1f@"\%!C0 W qivATlu1OJrc{,f4ˌ[$v
$('F>0P*.+U-C =/'4If Œ.:G6?{,>3\`H(vzwLm^#GLRjU5=9@p0DLq3ђ@C-Oۭ^R)@/*&o@M
hv3Z3h9WXM^רm-e ^Ĝө_QT"ŐZgKܚ&MupN/p<]d]DFE"jl}@B|T5zDAYjj'^d`YSl2:+vT!#pr7ֶ=MvG5y,p"ߝ˧L+n/9Zղ5Y%>cӑn
pjnV_誆NE,ck=BEukg--[
#"V"-o䅕Ŷj+}VF[*
>J?r՜yz\#
֎ǖ7-̱?ܾMnMRl4fzlf9`{6ZIEBMF<̶m]]6kDI#Eu w*NOUwh:/)|QyV5mE幛vJ}{ܝ=rpu%cav6䖦rz6q;ws$8qBpIdq0m # B j 5UK#䱪6e6
ڴVe6I*2M@Tjwg^:iw؉>C$FѬ!)91LA /
X*i[mSv.ƍp$gۂӔ`,m1*@9dSM 'L:bX^4*r4+ؘKߜ(IО